Erythrodysesthesia Syndrome
Showing 1 - 25 of >10,000
Erythrodysesthesia Syndrome Trial (Photobiomodulation, Moisturizer)
Not yet recruiting
- Erythrodysesthesia Syndrome
- Photobiomodulation
- Moisturizer
- (no location specified)
Dec 24, 2022
Palmar-Plantar Erythrodysesthesia, Palmar-Plantar Erythrodysesthesia Due to Cytotoxic Therapy Trial in Kuching (Moisturising
Recruiting
- Palmar-Plantar Erythrodysesthesia
- Palmar-Plantar Erythrodysesthesia Due to Cytotoxic Therapy
- Moisturising cream containing palm-oil derived vitamin E concentrate and urea cream
- +2 more
-
Kuching, Sarawak, MalaysiaSarawak General Hospital
Jul 2, 2023
Hand and Foot Syndrome, Erythrodysesthesia Syndrome, HFS Trial in Tanta (Celecoxib 200mg, Capecitabine-based chemo)
Recruiting
- Hand and Foot Syndrome
- +3 more
- Celecoxib 200mg
- Capecitabine-based chemotherapy
-
Tanta, EgyptFaculty of Pharmacy-Tanta University
Apr 7, 2022
Breast Cancer, Chemotherapeutic Agent Toxicity, Palmar-plantar Erythrodysesthesia Trial in San Francisco (Nicotine patch)
Terminated
- Breast Cancer
- +2 more
- Nicotine patch
-
San Francisco, CaliforniaUniversity of California, San Francisco
Sep 11, 2020
Palmar-plantar Erythrodysesthesia (PPE) Trial in Nicosia (Henna, Placebo)
Completed
- Palmar-plantar Erythrodysesthesia (PPE)
- Henna
- Placebo
-
Nicosia, CyprusAmerican Medical Centre
Oct 23, 2019
Hand and Foot Syndrome Trial in Cairo ((CARBAMIDE®), (VOLTAREN®) Emulgel 1%)
Recruiting
- Hand and Foot Syndrome
- (CARBAMIDE®)
- (VOLTAREN®) Emulgel 1%
-
Cairo, EgyptKASR ALAINY Center of Oncology and Nuclear medicine
Jan 26, 2023
Breast Cancer, Palmar-plantar Erythrodysesthesia Trial in Switzerland (antiperspirant cream F511, pegylated liposomal
Completed
- Breast Cancer
- Palmar-plantar Erythrodysesthesia
- antiperspirant cream F511
- pegylated liposomal doxorubicin hydrochloride
-
Aarau, Switzerland
- +14 more
May 14, 2019
Palmar-Plantar Erythrodysesthesia, Breast Cancer Trial in United States (Cream, 0.1% Uracil Cream)
Completed
- Palmar-Plantar Erythrodysesthesia
- Breast Cancer
- Cream
- 0.1% Uracil Cream
-
Birmingham, Alabama
- +5 more
Oct 5, 2019
Hand-foot Syndrome Trial in Shanghai (Gel containing Acetylated Natural Nucleotides, Vehicle Gel)
Recruiting
- Hand-foot Syndrome
- Gel containing Acetylated Natural Nucleotides
- Vehicle Gel
-
Shanghai, Shanghai, ChinaShanghai East Hospital
Dec 8, 2021
Adult T-Cell Lymphoma/Leukemia, Sezary Syndrome, Mycosis Fungoides Trial run by the NCI (Recombinant human Interleukin-15
Completed
- Adult T-Cell Lymphoma/Leukemia
- +2 more
- Recombinant human Interleukin-15 (rhIL-15)
- Mogamulizumab
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Dec 9, 2022
Pleomorphic Rhabdomyosarcoma, Stage IIB Adult Soft Tissue Sarcoma AJCC v7, Stage III Adult Soft Tissue Sarcoma AJCC v7 Trial in
Completed
- Pleomorphic Rhabdomyosarcoma
- +3 more
- Epirubicin Hydrochloride
- +5 more
-
Portland, OregonOHSU Knight Cancer Institute
Feb 23, 2022
Breast Cancer Trial in Boston (Nivolumab, Cabozantinib)
Completed
- Breast Cancer
-
Boston, MassachusettsDana-Farber Cancer Institute
Nov 29, 2021
Metastatic or Unresectable Solid Tumor Malignancy Trial in Fort Myers, Oklahoma City, Nashville (Capecitabine, Hsp90 Inhibitor
Completed
- Metastatic or Unresectable Solid Tumor Malignancy
- Capecitabine
- Hsp90 Inhibitor AUY 922
-
Fort Myers, Florida
- +2 more
Feb 15, 2022
Head and Neck Squamous Cell Carcinoma Trial in Norfolk, Omaha (Capecitabine, Docetaxel, Quality-of-Life Assessment)
Terminated
- Head and Neck Squamous Cell Carcinoma
- Capecitabine
- +3 more
-
Norfolk, Nebraska
- +2 more
Aug 10, 2022
Carcinoid Tumor Trial in Boston (Ziv-aflibercept)
Active, not recruiting
- Carcinoid Tumor
-
Boston, Massachusetts
- +2 more
Oct 14, 2022
Colon Adenocarcinoma, Rectal Adenocarcinoma, Stage III Colorectal Cancer AJCC v7 Trial in United States (Clobetasol Propionate,
Active, not recruiting
- Colon Adenocarcinoma
- +8 more
- Clobetasol Propionate
- +3 more
-
Phoenix, Arizona
- +21 more
Jan 5, 2022
Refractory Soft Tissue Sarcomas Trial run by the NCI (Cabozantinib)
Active, not recruiting
- Refractory Soft Tissue Sarcomas
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 5, 2022
Pancreas Cancer, Pancreatic Cancer, Cancer of the Pancreas Trial in Saint Louis (Dapagliflozin, BIOSENSE meters)
Completed
- Pancreas Cancer
- +2 more
- Dapagliflozin
- BIOSENSE meters
-
Saint Louis, MissouriWashington University School of Medicine
Dec 20, 2022
Palmar-Plantar Erythrodysesthesia Trial in Limassol, Nicosia (Vitamin B6 cream, Placebo Vitamin B6 cream)
Completed
- Palmar-Plantar Erythrodysesthesia
- Vitamin B6 cream
- Placebo Vitamin B6 cream
-
Limassol, Cyprus
- +1 more
Aug 6, 2018
Renal Cell Carcinoma Trial in United States (everolimus and bevacizumab)
Completed
- Renal Cell Carcinoma
- everolimus and bevacizumab
-
Basking Ridge, New Jersey
- +6 more
Jan 3, 2022
Acute Myeloid Leukemia, Adult Acute Megakaryoblastic Leukemia, Adult Acute Monoblastic Leukemia Trial in United States
Completed
- Acute Myeloid Leukemia
- +19 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +8 more
-
Lewes, Delaware
- +16 more
Aug 3, 2022
Advanced Lymphoma, Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (FGFR Inhibitor
Completed
- Advanced Lymphoma
- +5 more
- FGFR Inhibitor AZD4547
-
Philadelphia, PennsylvaniaECOG-ACRIN Cancer Research Group
Jun 8, 2021
Alveolar Soft Part Sarcoma, Soft Tissue Sarcomas Trial in Miami (Axitinib, Pembrolizumab)
Active, not recruiting
- Alveolar Soft Part Sarcoma
- Soft Tissue Sarcomas
-
Miami, FloridaUniversity of Miami
Dec 29, 2022